Biocon to consider and approve unaudited quarterly Q3 results

08 Jan 2013 Evaluate
Biocon has informed that a meeting of the Board of directors of the company will be held on January 24, 2013, to consider and approve the unaudited financial results of the company for the quarter ended December 31, 2012.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

390.25 -5.00 (-1.27%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×